Science Explorer Back to mapMap
Discussion

Orbis Health Solutions (United States)

Research works
3
▼ 86% vs 2018-21
Citations
19
7.0 per fractional work
Top-10% rate
9.5%
all institutions 10.0%
Open access
55%
world 40%
International
23%
world 18%
Orbis Health Solutions (United States)

Not ranked overall: Orbis Health Solutions (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Orbis Health Solutions (United States) work in?

In all years, 73% of research at Orbis Health Solutions (United States) is in Life Sciences, 23% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (38%), Immunology and Microbiology (35%), Medicine (23%). It does 1.4× the world's share of Life Sciences.

Life Sciences73%Physical Sciences4%Health Sciences23%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology138.5%
    2. Immunology and Microbiology134.6%
    1. Medicine123.1%
    1. Chemistry03.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Orbis Health Solutions (United States)?

The most cited paper from Orbis Health Solutions (United States) is "A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis" (Timothy J. Vreeland, Guy Travis Clifton, Diane F. Hale et al., 2021), with 41 citations. Next come "Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis" (24) and "Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors" (24).

All 11 most cited papers, with filters and sorting

Which research topics does Orbis Health Solutions (United States) publish most on?

By volume in 2022-now: Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management, Immune responses and vaccinations and Cancer Immunotherapy and Biomarkers.

  1. 1 Immunotherapy and Immune Responses Immunology 0 works
  2. 2 Cutaneous Melanoma Detection and Management Oncology 0 works
  3. 3 Immune responses and vaccinations Immunology 0 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 vaccines and immunoinformatics approaches Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.4%not open44.6%

World: 40% of research is openly available.

with international co-authors23.3%domestic only76.7%

World: 18% is written across borders.

How has Orbis Health Solutions (United States)'s research output changed?

Output in 2022-2025 was 86% lower than in 2018-2021.

20152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Orbis Health Solutions (United States) as a percentage of every work published that year, 0.0000013% in 2023.

0.0000050%0.000010%0.000015%Orbis Health Solutions (United States)0.0000013% in 20242020

Fractional works of Orbis Health Solutions (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Greenville

All research institutions in Greenville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Orbis Health Solutions (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.